Hypertensive kidney disease with kidney failure
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Chronic renal patients aged 18 to 40 years who undergo hemodialysis who are previously non-reactive (anti-HBS less than 10 UI/mL) will be included
Exclusion criteria
Exclusion criteria: Systemic lupus erythematosus; malignant neoplasm; hepatitis B; AIDS and use of immunosuppressive drugs will be excluded; history of allergic reaction to the Hepatitis B vaccine or any of its components; patients with serology bigger then 10UI/mL in the last 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| If there is a difference in the titration related to the moment of immunobiological administration before or after the hemodialysis session, through the evaluation of the anti-Hbs test one month after the intervention. The comparison measure will be through laboratory tests performed previously by the hemodialysis clinic service. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are not expected. | — |
Countries
Brazil
Contacts
Programa de Pós Graduação em Enfermagem